Overview Financials News + Filings Key Docs Charts Holdings Ownership Insiders
All All (ex-4s) 10-K 10-Q 8-K 3,4,5 Proxy Prospectus Other
Tags Inv. presentation Quarterly results Director departure Appointed director
|
EAGLE PHARMACEUTICALS, INC. (EGRX)
|
Create: Alert |
All | News | Filings
Date Filed | Type | Description |
01/10/2023 |
8-K/A
| Regulation FD Disclosure, Financial Statements and Exhibits Interactive Data |
11/09/2022 |
8-K/A
| Quarterly results |
08/25/2022 |
8-K/A
| Financial Statements and Exhibits Interactive Data
Docs:
|
"CONSENT OF INDEPENDENT AUDITORS",
"Report of Independent Auditors",
"UNAUDITED PRO FORMA CONDENSED COMBINED FINANCIAL INFORMATION Introduction The following unaudited pro forma condensed combined financial information , which includes the unaudited pro forma combined statement of operations for the six months ended June 30, 2022 and for the year ended December 31, 2021 , has been prepared on the basis set out in the notes below to illustrate the effect of the transaction. On June 9, 2022, Eagle Pharmaceuticals, Inc. completed the acquisition of Acacia Pharma Group plc , pursuant to the terms of a Scheme Document relating to the Acquisition published by Acacia on April 27, 2022 . In connection with the consummation of the Acquisition each Acacia shareholder became entitled to receive €0.68 in cash and 0.0049 shares of common stock of the Company for eac..." |
|
08/04/2022 |
8-K/A
| Submission of Matters to a Vote of Security Holders Interactive Data |
11/08/2021 |
8-K/A
| Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements... |
12/28/2020 |
8-K/A
| Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements... |
10/11/2019 |
8-K/A
| Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements... |
02/01/2017 |
8-K/A
| Form 8-K/A - Current report [Amend] |
04/21/2016 |
8-K/A
| Form 8-K/A - Current report [Amend] |
09/21/2015 |
8-K/A
| Regulation FD Disclosure, Financial Statements and Exhibits |
|
|